We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Denali Therapeutics Inc | NASDAQ:DNLI | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.06 | -0.29% | 20.80 | 20.00 | 20.79 | 580 | 13:59:41 |
|
Delaware
|
|
001-38311
|
|
46-3872213
|
(State or other jurisdiction of
|
|
(Commission
|
|
(I.R.S. Employer
|
incorporation)
|
|
File Number)
|
|
Identification No.)
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
|
|
|
|
Item 8.01
|
Other Events.
|
|
|
DENALI THERAPEUTICS INC.
|
|
|
|
|
|
Date:
|
January 4, 2019
|
By:
|
/s/ Steve E. Krognes
|
|
|
|
Steve E. Krognes
|
|
|
|
Chief Financial Officer
|
1 Year Denali Therapeutics Chart |
1 Month Denali Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions